UK regulators say extra AstraZeneca Covid-19 vaccine data highlights efficacy in elderly

UK regulators say extra AstraZeneca Covid-19 vaccine data highlights efficacy in elderly
UK regulators say extra AstraZeneca Covid-19 vaccine data highlights efficacy in elderly

Hello and welcome to the details of UK regulators say extra AstraZeneca Covid-19 vaccine data highlights efficacy in elderly and now with the details

Nevin Al Sukari - Sana'a - British regulators have received extra trial data from AstraZeneca that supports their view that the Covid-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said today. — AFP pic

LONDON, Feb 5 — British regulators have received extra trial data from AstraZeneca that supports their view that the Covid-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said today.

Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December, but some other European countries have said more data is needed before it is given to those over 65.

Munir Pirmohamed, Chair of the Commission on Human Medicines’ Covid-19 Vaccines Benefit Risk Expert Working Group said British regulators had noticed the smaller number of under-65s in the data when they approved the vaccine.

“Nevertheless, there was no evidence there, suggesting that those people over 65 were not getting evidence of efficacy,” he said at an MHRA news briefing, asked by Reuters about efficacy of the shot in the elderly.

“Since then we’ve seen more data coming through from AstraZeneca as more people are completing the trial, which highlights again that efficacy in the elderly is seen, and there’s no evidence of lack of efficacy.”

He added elderly people were generating strong immune responses, and said that the most important thing was that both AstraZeneca’s vaccine and a shot developed by Pfizer and BioNTech were preventing serious disease and deaths.

President of the European Commission Ursula von der Leyen has said that the EU has decided not to compromise on safety as she defends the slower pace of approval of shots in the bloc.

Asked about the suggestion that Britain had compromised on safety and efficacy standards, MHRA Chief Executive June Raine defended the regulator’s standards.

“I think our position is very clear in terms of the rigorous science that MHRA pursues in the interests of public confidence, public safety, and the effectiveness of these important vaccines,” she said. — Reuters

These were the details of the news UK regulators say extra AstraZeneca Covid-19 vaccine data highlights efficacy in elderly for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Netanyahu loses mandate to form Israel govt, opening door for rivals
NEXT India's lauds Gulf assistance in fighting COVID-19